Innovative Neurotherapy Nia Therapeutics is developing a cutting-edge, AI-driven neurostimulation therapy targeting memory loss, with a focus on traumatic brain injury, providing opportunities to collaborate with healthcare providers specializing in neurorehabilitation and cognitive treatments.

Market Potential With over 27 million Americans affected by memory loss from various causes, Nia is positioned to address a significant and growing market, including the larger mild cognitive impairment and Alzheimer's segments, opening avenues for partnerships with medical institutions and insurers.

Strategic Partnerships Recent collaborations with organizations serving underserved communities suggest opportunities to expand sales through community health programs and publicly funded health initiatives aiming to reduce healthcare disparities.

Technology Stack Utilizing advanced design and programming tools like SOLIDWORKS, Autodesk Fusion 360, and Python enables Nia to maintain innovative product development, aligning with manufacturers and research organizations seeking modern medical device solutions.

Funding and Growth With substantial funding of $10M and revenue up to $10M, Nia demonstrates scalable growth potential, making it a promising partner for investors, research grants, and early adopters in the neurotechnology field.